These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Treatment of intermittent claudication with antiplatelet agents. Giansante C; Calabrese S; Fisicaro M; Fiotti N; Mitri E J Int Med Res; 1990; 18(5):400-7. PubMed ID: 2147914 [TBL] [Abstract][Full Text] [Related]
24. [Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions]. Ostendorf P Internist (Berl); 1979 Nov; 20(11):539-46. PubMed ID: 396265 [No Abstract] [Full Text] [Related]
25. Antithrombotic treatment. Buckler P; Douglas AS Br Med J (Clin Res Ed); 1983 Jul; 287(6386):196-8. PubMed ID: 6191822 [No Abstract] [Full Text] [Related]
26. [Role of antiaggregant platelet drugs in thromboembolism]. Tullio D G Ital Cardiol; 1981; 11(8):1131-40. PubMed ID: 6173281 [No Abstract] [Full Text] [Related]
27. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link. de Gaetano G; Cerletti C; Bertelè V Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469 [No Abstract] [Full Text] [Related]
28. [Prevention of thrombosis and embolism in digestive surgery]. Uhl JF; Huguier M J Chir (Paris); 1979 Mar; 116(3):209-24. PubMed ID: 385607 [No Abstract] [Full Text] [Related]
29. [State of thrombosis risk: diagnostic and preventive possibilities]. Dmoszyńska-Giannopoulou A; Pluta A Pol Arch Med Wewn; 1979 Dec; 62(6):563-8. PubMed ID: 394126 [No Abstract] [Full Text] [Related]
30. Prevention of stroke. Barnett HJ Int Anesthesiol Clin; 1984; 22(3):11-29. PubMed ID: 6384054 [No Abstract] [Full Text] [Related]
31. [Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)]. Köhler H Klin Wochenschr; 1977 Jan; 55(2):49-56. PubMed ID: 834017 [TBL] [Abstract][Full Text] [Related]
32. [Which procedure is effective: anticoagulants, dextran, or early mobilization]. Breddin K Med Welt; 1976 Jun; 27(25):1238-41. PubMed ID: 933810 [No Abstract] [Full Text] [Related]
33. Use of common antiplatelet drugs for vascular diseases. Pagano T; Nair CK; Sketch MH Geriatrics; 1983 Nov; 38(11):75-95. PubMed ID: 6605278 [No Abstract] [Full Text] [Related]
34. Prevention and management of venous thrombosis and pulmonary embolism. Mandel SR; Johnson G N C Med J; 1973 Feb; 34(2):114-9. PubMed ID: 4568848 [No Abstract] [Full Text] [Related]
35. [New possibilities in the prevention of thrombosis]. Kummer H Schweiz Rundsch Med Prax; 1973 May; 62(20):619-25. PubMed ID: 4702970 [No Abstract] [Full Text] [Related]
36. [Possibilities of drug-induced prevention of thrombosis with special reference to pre-, per- and postoperative time of treatment]. Fisher M Zentralbl Chir; 1977; 102(8):449-58. PubMed ID: 327730 [TBL] [Abstract][Full Text] [Related]
37. [Treatment and prevention of thromboembolism with anti-aggregation drugs]. Donner L Vnitr Lek; 1981 May; 27(5):487-95. PubMed ID: 7245635 [No Abstract] [Full Text] [Related]
38. [Anticoagulants in neurology]. Gänshirt H Med Welt; 1978 Dec; 29(51-52):2015-8. PubMed ID: 723605 [No Abstract] [Full Text] [Related]
39. [Benefits and dangers of preventive thinking in medicine--prevention of thromboembolism]. Bolte HD Internist (Berl); 1981 Feb; 22(2):72-8. PubMed ID: 6163745 [No Abstract] [Full Text] [Related]
40. [Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey]. Spitzer W; Durst OE; Lang E Fortschr Med; 1983 Jan; 101(1-2):22-30. PubMed ID: 6826125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]